Microtubule-stabilizing drugs from marine sponges: Focus on peloruside A and zampanolide

Marine Drugs

Volumn 8, Issue 4, 2010, Pages 1059-1079

  Miller, John H ^a   Singh, A Jonathan ^a   Northcote, Peter T ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Microtubule stabilization; Mycalamide; Pateamine; Peloruside; Zampanolide

Indexed keywords

18 O METHYLMYCALAMIDE B; ANTINEOPLASTIC AGENT; CASTOR OIL; DENDROLASIN; DOCETAXEL; DRUG VEHICLE; ISOLAULIMALIDE; LATRUNCULIN A; LAULIMALIDE; MICROTUBULE STABILIZING AGENT; MYCALAMIDE A; MYCALAMIDE B; MYCALAMIDE C; MYCALAMIDE D; MYCALAMIDE DERIVATIVE; MYCOTHIAZOLE; NATURAL PRODUCT; PACLITAXEL; PATEAMINE; PEDERIN; PELORUSIDE A; PELORUSIDE DERIVATIVE; TUBULIN; UNCLASSIFIED DRUG; ZAMPANOLIDE;

ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG BINDING SITE; DRUG DETERMINATION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HEAD AND NECK CANCER; HUMAN; IMMUNOMODULATION; LUNG CANCER; LYMPHOMA; MICROTUBULE; MULTIPLE SCLEROSIS; NONHUMAN; OVARY CANCER; REVIEW; SOLID TUMOR; SPONGE (PORIFERA); UNSPECIFIED SIDE EFFECT;

CACOSPONGIA; MYCALE HENTSCHELI; TAXUS BREVIFOLIA;

EID: 77952565282     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md8041059     Document Type: Review

References (127)

1. Paterson, I.; Anderson, E.A. The renaissance of natural products as drug candidates. Science 2005, 310, 451-453. (Pubitemid 41507948)
2. Newman, D.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461-477.
3. Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. Drug development from marine natural products. Nat. Rev. Drug Discov. 2009, 8, 69-85.
4. Cragg, G.M.; Grothaus, P.G.; Newman, D.J. Impact of natural products on developing new anticancer agents. Chem. Rev. 2009, 109, 3012-3043.
5. Sashidara, K.V.; White, K.N.; Crews, P. A selective account of the effective paradigms and significant outcomes in the discovery of inspirational marine natural products. J. Nat. Prod. 2009, 72, 588-603.
6. Napolitano, J.G.; Daranas, A.H.; Norte, M.; Fernández, J.J. Marine macrolides, a promising source of antitumor compounds. Anti-Cancer Agents Med. Chem. 2009, 9, 122-137.
7. Blunt, J.W.; Copp, B.R.; Hu, W.-P.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2009, 26, 170-244, and previous reviews in this series.
8. Belarbi, E.H., Contreras Gomez, A.; Chisti, Y.; García Camacho, F.; Molina Grima, E. Producing drugs from marine sponges. Biotechnol. Adv. 2003, 21, 585-598.
9. Haefner, B. Drugs from the deep: Marine natural products as drug candidates. Drug Discov. Today 2009, 8, 536-544.
10. Mestel, R. Drugs from the sea. Discover 1999, March, 71-74.
11. Simmons, T.L.; Andrianasolo, E.; McPhail, K.; Flatt, P.; Gerwick, W.H. Marine natural products as anticancer drugs. Mol. Cancer Ther. 2005, 4, 333-342.
12. Singh, R.; Sharma, M.; Joshi, P.; Rawat, D.S. Clinical status of anti-cancer agents derived from marine sources. Anticancer Agents Med. Chem. 2008, 8, 603-617.
13. Sipkema, D.; Franssen, M.C.R.; Osinga, R.; Tramper, J.; Wijffels, R.H. Marine sponges as pharmacy. Mar. Biotech. 2005, 7, 142-162.
14. Flam, F. Chemical prospectors scour the seas for promising drugs. Science 1994, 266, 1324-1325.
15. Davidson, B.S. New dimensions in natural products research: cultured marine microorgansims. Curr. Opin. Biotech. 1995, 6, 284-291.
16. Bentley, R. Microbial secondary metabolites play important roles in medicine: Prospects for discovery of new drugs. Perspect. Biol. Med. 1997, 40, 364-395.
17. Bewley, C.A.; Faulkner, D.J. Lithistid sponges: Star performers or hosts to the stars. Angew Chem. Int. Ed. 1998, 37, 2162-2178.
18. Fusetani, N.; Kem, W. Marine toxins: an overview. Prog. Mol. Subcell. Biol. 2009, 46, 1-44.
19. Page, M.; West, L.; Northcote, P.; Battershill, C.; Kelly, M. Spatial and temporal variability of cytotoxic metabolites in populations of the New Zealand sponge Mycale hentscheli. J. Chem. Ecol. 2005, 31, 1161-1174.
20. Page, M.J.; Northcote, P.T.; Webb, V.L.; Mackey, S.; Handley, S.J. Aquaculture trials for the production of biologically active metabolites in the New Zealand sponge Mycale hentscheli (Demospongiae: Poecilosclerida). Aquaculture 2005, 250, 256-269.
21. Jordan, M.A.; Wilson, L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 1998, 10, 123-130.
22. Jordan, M.A.; Wilson, L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer. 2004, 4, 253-265.
23. Zhou, J.; Giannakakou, P. Targeting microtubules for cancer chemotherapy. Curr. Med. Chem.- Anti-Cancer Agents 2005, 5, 65-71.
24. Altmann, K.H.; Gertsch, J. Anticancer drugs from nature - natural products as a unique source of new microtubule-stabilizing agents. Nat. Prod. Rep. 2007, 24, 327-357. (Pubitemid 46504987)
25. Kingston, D.G.I. Tubulin-interactive natural products as anticancer agents. J. Nat. Prod. 2009, 72, 507-515.
26. Saito, S. Toxins affecting actin filaments and microtubules. Prog. Mol. Subcell. Biol. 2009, 46, 187-219.
27. Rowinsky, E.K.; Donehower, R.C. Paclitaxel (Taxol). New Engl. J. Med. 1995, 332, 1004-1014.
28. Rowinsky, E.K.; Calvo, E. Novel agents that target tublin and related elements. Semin. Oncol. 2006, 33, 421-435. (Pubitemid 44142739)
29. Morris, P.G.; Fornier, M.N. Microtubule active agents: Beyond the taxane frontier. Clin. Cancer Res. 2008, 14, 7167-7172.
30. Wani, M.C.; Taylor, H.L.; Wall, M.E.; Coggon, P.; McPhail, A.T. Plant antitumor agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 1971, 93, 2325-2327.
31. Schiff, P.B.; Fant, J.; Horwitz, S.B. Promotion of microtubule assembly in vitro by Taxol. Nature 1979, 277, 665-667.
32. Tinley, T.L.; Randall-Hlubek, D.A.; Leal, R.M.; Jackson, E.M.; Cessac, J.W.; Quada Jr., J.C.; Hemscheidt, T.K.; Mooberry, S.L. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity. Cancer Res. 2003, 63, 3211-3220.
33. Bollag, D.M.; McQueney, P.A.; Zhu, J.; Hensens, O.; Koupal, L.; Leisch, J.; Goetz, M.; Lazarides, E.; Woods, C.M. Epothilones, a new class of microtubule-stabilizing agents with a Taxol-like mechanism of action. Cancer Res. 1995, 55, 2325-2333.
34. Lindel, T.; Jensen, P.R.; Fenical, W.; Long, B.H.; Casazza, A.M.; Carboni, J.; Fairchild, C.R. Eleutherobin, a new cytotoxin that mimics paclitaxel (Taxol) by stabilizing microtubules. J. Am. Chem. Soc. 1997, 119, 8744-8745.
35. Long, B.H.; Carboni, J.M.; Wasserman, A.J.; Cornell, L.A.; Casazza, A.M.; Jensen, P.R.; Lindel, T.; Fenical, W.; Fairchild, C.R. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerisation, is similar to paclitaxel (Taxol). Cancer Res. 1998, 58, 1111-1115.
36. D'Ambrosio, M.; Guerriero, A.; Pietra, F. Sarcodictyin A and sarcodictyin B, novel diterpenoidic alcohols esterified by (E)-N(1)-methylurocanic acid. Isolation from the Mediterranean stolonifer Sarcodictyon roseum. Helv. Chim. Acta 1987, 70, 2019-2027.
37. Hamel, E.; Sackett, D.L.; Vourloumis, D.; Nicolaou, K.C. The coral-derived natural products eleutherobin and sarcodictyins A and B: Effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site. Biochemistry 1999, 38, 5490-5498. (Pubitemid 129514855)
38. Hood, K.A.; West, L.M.; Northcote, P.T.; Berridge, M.V.; Miller, J.H. Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine. Apoptosis 2001, 6, 207-219.
39. Hood, K.A.; Bäckström, B.T.; West, L.M.; Northcote, P.T.; Berridge, M.V.; Miller, J.H. The novel cytotoxic sponge metabolite peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C. Anti-Cancer Drug Des. 2001, 16, 155-166. (Pubitemid 34269750)
40. Miller, J.H.; Rouwé, B.; Gaitanos, T.N.; Hood, K.A.; Crume, K.P.; Bäckström, B.T.; La Flamme, A.C.; Berridge, M.V.; Northcote, P.T. Peloruside A enhances apoptosis in H-ras-transformed cells and is cytotoxic to proliferating T cells. Apoptosis 2004, 9, 785-796. (Pubitemid 40941207)
41. Perry, N.B.; Blunt, J.W.; Munro, M.H.G. Mycalamide A, an antiviral compound from a New Zealand sponge of the genus Mycale. J. Am. Chem. Soc. 1988, 110, 4850-4851.
42. Perry, N.B.; Blunt, J.W.; Munro, M.H.G.; Thompson, A.M. Antiviral and antitumor agents from a New Zealand sponge, Mycale sp. 2. Structures and solution conformations of mycalamides A and B. J. Org. Chem. 1990, 55, 223-227.
43. West, L.M.; Northcote, P.T.; Hood, K.A.; Miller, J.H.; Page, M.J. Mycalamide D, a new cytotoxic amide from the New Zealand marine sponge Mycale species. J. Nat. Prod. 2000, 63, 707-709. (Pubitemid 30395541)
44. Simpson, J.S.; Garson, M.J.; Blunt, J.W.; Munro, M.H.G.; Hooper, J.N.A. Mycalamides C and D, cytotoxic compounds from the marine sponge Stylinos n. species. J. Nat. Prod. 2000, 63, 704-706. (Pubitemid 30395540)
45. Cardani, C.; Ghiringhelli, D.; Mondelli, R.; Quilico, A. The structure of pederin. Tetrahedron Lett. 1965, 6, 2537-2545.
46. Soldati, M.; Fioretti, A.; Ghione, M. Cytotoxicity of pederin and some of its derivatives on cultured mammalian cells. Experientia 1966, 22, 176-178.
47. Kellner, R.L.L.; Dettner, K. Differential efficacy of toxic pederin in deterring potential arthropod predators of Paederus (Coleoptera: Staphylinidae) offspring. Oecologia 1996, 107, 293-300. (Pubitemid 26310768)
48. Sakemi, S.; Ichiba, T.; Kohmoto, S.; Saucy, G. Isolation and structure elucidation of onnamide A, a new bioactive metabolite of a marine sponge, Theonella sp. J. Am. Chem. Soc. 1988, 110, 4851-4853.
49. Matsunaga, S.; Fusetani, N.; Nakao, Y. Eight new cytotoxic metabolites closely related to onnamide A from two marine sponges of the genus Theonella. Tetrahedron 1992, 48, 8369-8376.
50. Kobayashi, J.; Itagaki, F.; Shigemori, H.; Sasaki, T. Three new onnamide congeners from the Okinawan marine sponge Theonella sp. J. Nat. Prod. 1993, 56, 976-981. (Pubitemid 23195635)
51. Vuong, D.; Capon, R.J.; Lacey, E.; Gill, J.H.; Heiland, K.; Friedel, T. Onnamide F: A new nematocide from a Southern Australian marine sponge, Trachycladus laevispirulifer. J. Nat. Prod. 2001, 64, 640-642.
52. Fusetani, N.; Sugawara, T.; Matsunaga, S. Theopederins A-E, potent antitumor metabolites from a marine sponge, Theonella sp. J. Org. Chem. 1992, 57, 3828-3832.
53. Tsukamoto, S.; Matsunaga, S.; Fusetani, N.; Toh-e, A. Theopederins F-J: Five new antifungal and cytotoxic metabolites from the marine sponge, Theonella swinhoei. Tetrahedron 1999, 55, 13697-13702.
54. Paul, G.K.; Gunasekera, S.P.; Longley, R.E.; Pomponi, S.A. Theopederins K and L. Highly potent cytotoxic metabolites from a marine sponge Discodermia species. J. Nat. Prod. 2002, 65, 59-61.
55. Burres, N.S.; Clement, J.J. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide. Cancer Res. 1989, 49, 2935-2940.
56. Carrasco, L.; Fernandez-Puentes, C.; Vazques, D. Antibiotics and compounds affecting translation by eukaryotic ribosomes. Specific enhancement of aminoacyl-tRNA binding by methylxanthines. Mol. Cell. Biochem. 1976, 10, 97-122.
57. Abell, A.D.; Blunt, J.W.; Foulds, G.J.; Munro, M.H.G. Chemistry of the mycalamides: antiviral and antitumor compounds from a New Zealand marine sponge. Part 6. The synthesis and testing of analogues of the C(7)-C(10) fragment. J. Chem. Soc. Perkin Trans. 1 1997, 1647-1654.
58. Gürel, G.; Blaha, G.; Steitz, T.A.; Moore, P.B. Structures of triacetyloleandomycin and mycalamide A bind to the large ribosomal subunit of Haloarcula marismortui. Antimicrob. Agents Chemother. 2009, 53, 5010-5014.
59. Hong, C.Y.; Kishi, Y. Total synthesis of mycalamides A and B. J. Org. Chem. 1990, 55, 4242-4245.
60. Roush, W.R.; Pfeifer, L.A. Total synthesis of mycalamide A and 7-epi-mycalamide A. Org. Lett. 2000, 2, 859-862.
61. Sohn, J.-H.; Waizumi, N.; Zhong, M.; Rawal, V.H. Total synthesis of mycalamide A. J. Am. Chem. Soc. 2005, 127, 7290-7291.
62. Kagawa, N.; Ihara, M.; Toyota, M. Convergent total synthesis of (+)-mycalamide A. J. Org. Chem. 2006, 71, 6796-6805.
63. Kagawa, N.; Ihara, M.; Toyota, M. Total synthesis of (+)-mycalamide A. Org. Lett. 2006, 8, 875-878.
64. Thompson, A.M.; Blunt, J.W.; Munro, M.H.G.; Perry, N.B.; Pannell, L.K. Chemistry of the mycalamides, antiviral and antitumour compounds from a marine sponge. Part 3. Acyl, alkyl and silyl derivatives. J. Chem. Soc., Perkin Trans. 1 1992, 1335-1342.
65. Thompson, A.M.; Blunt, J.W.; Munro, M.H.G.; Clark, B.M. Chemistry of the mycalamides, antiviral and antitumour compounds from a marine sponge. Part 4. Reactions of mycalamide A and alkyl derivatives with basic nucleophiles. J. Chem. Soc., Perkin Trans. 1 1994, 1025-1031.
66. Thompson, A.M.; Blunt, J.W.; Munro, M.H.G.; Perry, N.B. Chemistry of the mycalamides, antiviral and antitumor compounds from a marine sponge. Part 5. Acid-catalysed hydrolysis and acetal exchange, double bond additions and oxidation reactions. J. Chem. Soc., Perkin Trans. 1 1995, 1233-1242.
67. Fukui, H.; Tsuchiya, Y.; Fujita, K.; Nakagawa, T.; Koshino, K.; Nakata, T. Synthesis and biological activity of artificial analogs of mycalamide A. Bioorg. Med. Chem. Lett. 1997, 7, 2081-2086.
68. Richter, A.; Kocienski, P.; Raubo, P.; Davies D. The in vitro biological activities of synthetic 18- O-methyl mycalamide B, 10-epi-18-O-methyl mycalamide B and pederin. Anticancer Drug Des. 1997, 12, 217-227.
69. Northcote, P.T.; Blunt, J.W.; Munro, M.H.G. Pateamine: a potent cytotoxin from the New Zealand marine sponge, Mycale sp. Tetrahedron Lett. 1991, 32, 6411-6414.
70. Romo, D.; Rzasa, R.M.; Shea, H.A.; Park, K.; Langenhan, J.M.; Sun, L.; Akhiezer, A.; Liu, J.O. Total synthesis and immunosuppressive activity of (-)-pateamine A and related compounds: Implementation of a β-lactam-based macrocyclization. J. Am. Chem. Soc. 1998, 120, 12237-12254.
71. Licitra, E.J.; Liu, J.O. A three-hybrid system for detecting small ligand-protein receptor interactions. Proc. Nat. Acad. Sci. USA 1996, 93, 12817-12821.
72. Bordeleau, M.E.; Matthews, J.; Wojnar, J.; Lindqvist, L.; Novac, O.; Jankowsky, E.; Sonenberg, N.; Northcote, P.; Teesdale-Spittle, P.; Pelletier, J. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation. Proc. Nat. Acad. Sciences USA 2005, 102, 10460-10465.
73. Low, W.K.; Dang, Y.; Schneider-Poetsch, T.; Shi, Z.; Choi, N.S.; Merrick, W.C.; Romo, D.; Liu, J.O. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A. Mol. Cell 2005, 20, 709-722.
74. Low, W.K.; Dang, Y.; Schneider-Poetsch, T.; Shi, Z.; Choi, N.S.; Rzasa, R.M.; Shea, H.A.; Li, S.; Park, K.; Ma, G.; Romo, D.; Liu, J.O. Isolation and identification of eukaryotic initiation factor 4A as a molecular target for the marine natural product Pateamine A. Meth. Enzymol. 2007, 431, 303-324.
75. Dang, Y.; Low, W.K.; Xu, J.; Gehring, N.H.; Dietz, H.C.; Romo, D.; Liu, J.O. Inhibition of nonsense-mediated mRNA decay by the natural product pateamine A through eukaryotic initiation factor 4AIII. J. Biol. Chem. 2009, 284, 23613-23621.
76. West, L.M.; Northcote, P.T.; Battershill, C.N. Peloruside A: A potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp. J. Org. Chem. 2000, 65, 445-449. (Pubitemid 30061125)
77. Hood, K.A.; West, L.M.; Rouwé, B.; Northcote, P.T.; Berridge, M.V.; Wakefield, St.J.; Miller, J.H. Peloruside A, a novel anti-mitotic agent with paclitaxel-like microtubule-stabilizing activity. Cancer Res. 2002, 62, 3356-3360. (Pubitemid 34651377)
78. Rowinsky, E.K.; Eisenhauer, E.A.; Chaudhry, V.; Arbuck, S.G.; Donehower, R.C. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol. 1993, 20, 1-15.
79. Horwitz, S.B. Personal recollections on the early development of Taxol. J. Nat. Prod. 2004, 67, 136-138.
80. Díaz, J.F.; Andreu, J.M. Assembly of purified GDP-tubulin into microtubules induced by Taxol and Taxotere: Reversibility, ligand stoichiometry, and competition. Biochemistry 1993, 32, 2747-2755. (Pubitemid 23102795)
81. Gaitanos, T.N.; Buey, R.M.; Díaz, J.F.; Northcote, P.T.; Teesdale-Spittle, P.; Andreu, J.M.; Miller, J.H. Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug resistant cell lines. Cancer Res. 2004, 64, 5063-5067. (Pubitemid 39006519)
82. Kowalski, R.J.; Giannakakou, P.; Gunasekera, S.P.; Longley, R.E.; Day, B.W.; Hamel, E. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Mol. Pharmacol. 1997, 52, 613-622. (Pubitemid 27443983)
83. Yvon, A-M.C.; Wadsworth, P.; Jordan M.A. Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol. Biol. Cell 1999, 10, 947-959.
84. Kamath, K.; Jordan, M.A. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest. Cancer Res. 2003, 63, 6026-6031.
85. Honore, S.; Kamath, K.; Braguer, D.; Wilson, L.; Briand, C.; Jordan, M.A. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation. Mol. Cancer Ther. 2003, 2, 1303-1311.
86. Honore, S.; Kamath, K.; Braguer, D.; Horwitz, S.B.; Wilson, L.; Briand, C.; Jordan, M.A. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells. Cancer Res. 2004, 64, 4957-4964.
87. Chan, A.; Andreae, P.; Northcote, P.T.; and Miller, J.H. Peloruside A inhibits microtubule dynamics in a breast cancer cell line MCF7. Invest. New Drugs 2010, DOI 10.1007/s10637-010-9398-2.
88. Wilmes, A.; Rawson, P.; Peng, L.; McLauchlan, D.; Northcote, P.T.; Jordan, T.W.; Miller, J.H. Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells. Invest. New Drugs 2010, DOI 10.1007/s10637-010-9387-5.
89. Hermeking, H.; Eick, D. Mediation of c-Myc-induced apoptosis by p53. Science 1994, 265, 2091-2093.
90. Pryor, D.E.; O'Brate, A.; Bilcer, G.; Díaz, J.F.; Wang, Y.; Wang, Y.; Kabaki, M.; Jung, M.K.; Andreu, J.M.; Ghosh, A.K.; Giannakakou, P.; Hamel, E. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry 2002, 41, 9109-9115.
91. Nogales, E.; Wolf, S.G.; Khan, I.A.; Ludueña, R.F.; Downing, K.H. Structure of tubulin at 6.5 Å and location of the taxol-binding site. Nature 1995, 375, 424-427.
92. Downing, K.H. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annu. Rev. Cell Dev. Biol. 2000, 16, 89-111.
93. Hamel, E.; Day, B.W.; Miller, J.H.; Jung, M.K.; Northcote, P.T.; Ghosh, A.K.; Curran, D.P.; Cushman, M.; Nicolaou, K.C.; Paterson, I.; Sorensen, E.J. Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly. Mol. Pharmacol. 2006, 70, 1555-1564.
94. Wilmes, A.; Bargh, K.; Kelly, C.; Northcote, P.T.; Miller, J.H. Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines. Mol. Pharm. 2007, 4, 269-280.
95. Huzil, J.T.; Chik, J.K.; Slysz, G.W.; Freedman, H.; Tuszynski, J.; Taylor, R.E.; Sackett, D.L.; Schriemer, D.C. A unique mode of microtubule stabilization induced by peloruside A. J. Mol. Biol. 2008, 378, 1016-1030.
96. Pineda, O.; Farràs, J.; Maccari, L.; Manetti, F.; Botta, M.; Vilarrasa, J. Computational comparison of microtubule-stabilizing agents laulimalide and peloruside with taxol and colchicine. Bioorg. Med. Chem. Lett. 2004, 14, 4825-4829.
97. Jiménez-Barbero, J.; Canales, A.; Northcote, P.T.; Buey, R.M.; Andreu, J.M.; Díaz, J.F. NMR determination of the bioactive conformation of peloruside A bound to microtubules. J. Am. Chem. Soc. 2006, 128, 8757-8765.
98. Barberis, A.; Gunde, T.; Berset, C.; Audetat, S.; Lüthi, U. Yeast as a screening tool. Drug Discov. Today: Technol. 2005, 2, 187-192.
99. Bode, C.J.; Gupta Jr., M.L.; Reiff, E.A.; Suprenant, K.A.; Georg, G.I.; Himes, R.H. Epothilone and paclitaxel: unexpected differences in promoting the assembly and stabilization of yeast microtubules. Biochemistry 2002, 41, 3870-3874.
100. Gupta Jr., M.L.; Bode, C.L.; Georg, G.L.; Himes, R.H. Understanding tubulin-Taxol interactions: Mutations that impart Taxol binding to yeast tubulin. Proc. Nat. Acad. Sci. USA 2003, 100, 6394-6397.
101. Tong, A.H.Y.; Evangelista, M.; Parsons, A.B.; Xu, H.; Bader, G.D.; Pagé, N.; Robinson, M.; Raghibizadeh, S.; Hogue, C.W.V.; Bussey, H.; Andrews, B.; Tyers, M.; Boone, C. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 2001, 294, 2364-2368.
102. Giaever, G.; Flaherty, P.; Kumm, J.; Proctor, M.; Nislow, C.; Jaramillo, D.F.; Chu, A.M.; Jordan, M.I.; Arkin, A.P.; Davis, R.W. Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast. Proc. Nat. Acad. Sci. USA 2004, 101, 793-798.
103. Vanhecke, D.; Janitz, M. High-throughput gene silencing using cell arrays. Oncogene 2004, 23, 8353-8358. (Pubitemid 39540716)
104. Whitehurst, A.W.; Bodemann, B.O.; Cardenas, J.; Ferguson, D.; Girard, L.; Peyton, M.; Minna, J.D.; Michnoff, C.; Hao, W.; Roth, M.G.; Xie, X.J.; White, M.A. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007, 446, 815-819.
105. Schadt, E.E.; Friend, S.H.; Shaywitz, D.A. A network view of disease and compound screening. Nat. Rev. Drug Discov. 2009, 8, 286-295.
106. Costanzo, M.; Baryshnikova, A.; Bellay, J.; Kim, Y.; Spear, E.D.; Sevier, C.S.; Ding, H.; Koh, J.L.Y.; Toufighi, K.; Mostafavi, S.; et al. The genetic landscape of a cell. Science 2010, 327, 425-431.
107. Khrapunovich-Baine, M.; Menon, V.; Verdier-Pinard, P.; Smith III, A.B.; Angeletti, R.H.; Fiser, A.; Horwitz, S.B.; Xiao, H. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization. Biochemistry 2009, 48, 11664-11677.
108. Xiao, H.; Verdier-Pinard, P.; Fernandez-Fuentes, N.; Burd, B.; Angeletti, R.; Fiser, A.; Horwitz, S.B.; Orr, G.A. Insights into the mechanism of microtubule stabilization by Taxol. Proc. Nat. Acad. Sci. USA 2006, 103, 10166-10173.
109. Singh, A.J.; Xu, C-X.; Xu, X.; West, L.M.; Wilmes, A.; Chan, A.; Hamel, E.; Miller, J.H.; Northcote, P.T.; Ghosh, A.K. Peloruside B, a potent antitumor macrolide from the New Zealand marine sponge Mycale hentscheli: Isolation, structure, total synthesis and bioactivity. J. Org. Chem. 2010, 75, 2-10.
110. Northcote, P.T.; Miller, J.H.; West, L.M.; Hood, K.A. Bioactive compound (Peloruside A). US Patent Number US 6,790,862 B2, September 14, 2004.
111. Meyer, C.; Ferguson, D.; Krauth, M.; Wick, M.; Northcote, P. RTA 301 (peloruside): a novel microtubule stabilizer with potent in vivo activity against lung cancer and resistant breast cancer. In 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Prague, Czech Republic, November 7-10, 2006; Abstr No. 639. Available online: http://www.sciencedirect. com/science/article/B75GT4MMF4DMST/2/901656de391d50b1ced 2b 7ad843d922a. doi:10.1016/S1359-6349(06)70644-9.
112. Crume, K.P.; O'Sullivan, D.; Miller, J.H.; Northcote, P.T.; La Flamme, A.C. Delaying the onset of experimental autoimmune encephalomyelitis with the microtubule-stabilizing compounds, paclitaxel and peloruside A. J. Leukocyte Biol. 2009, 86, 949-958.
113. Brunden, K.R.; Trojanowski, J.Q.; Lee, V.M.-Y. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat. Rev. Drug Discov. 2009, 8, 783-793.
114. Liao, X.; Wu, Y.; De Brabander, J.K. Total synthesis of peloruside A. Angew Chem. Int. Ed. 2003, 42, 1648-1652.
115. Jin, M.; Taylor, R.E. Total synthesis of (+)-peloruside A. Org Lett. 2005, 7, 1303-1305.
116. Ghosh, A.K.; Xu, X.; Kim, J.H.; Xu, C.X. Enantioselective total synthesis of peloruside A: a potent microtubule stabilizer. Org. Lett. 2008, 10, 1001-1004.
117. Evans, D.A.; Welch, D.S.; Speed, A.W.; Moniz, G.A.; Reichelt, A; Ho, S. An aldol-based synthesis of (+)-peloruside a, a potent microtubule stabilizing agent. J. Am. Chem. Soc. 2009, 131, 3840-3841.
118. Williams, D.R.; Nag, P.P.; Zorn, N. Strategies for the synthesis of the novel antitumor agent peloruside A. Curr. Opin. Drug Discov. Devel. 2008, 11, 251-271.
119. Uenishi, J.; Iwamoto, T.; Tanaka, J. Total synthesis of (-)-zampanolide and questionable existence of (-)-dactylolide as the elusive biosynthetic precursor of (-)-zampanolide in an Okinawan sponge. Org. Lett. 2009, 11, 3262-3265.
120. Tanaka, J.; Higa, T. Zampanolide, a new cytotoxic macrolide from a marine sponge. Tetrahedron Lett. 1996, 37, 5535-5538.
121. Smith III, A.B.; Safonov, I.G.; Corbett, R.M. Total syntheses of (+)-zampanolide and (+)-dactylolide exploiting a unified strategy. J. Am. Chem. Soc. 2002, 124, 11102-11113.
122. Field, J.J.; Singh, A.J.; Kanakkanthara, A.; Halafihi, T.; Northcote, P.T.; Miller, J.H. Microtubule-stabilizing activity of Zampanolide, a potent macrolide isolated from the Tongan marine sponge Cacospongia mycofijiensis. J. Med. Chem. 2009, 52, 7328-7332.
123. Smith III, A.B.; Safonov, I.G.; Corbett, R.M. Total synthesis of (+)-zampanolide. J. Am. Chem. Soc. 2001, 123, 12426-12427.
124. Ding, F.; Jennings, M.P. Total synthesis of (-)-dactylolide and formal synthesis of (-)-zampanolide via target oriented β-C-glycoside formation. J. Org. Chem. 2008, 73, 5965-5976.
125. Ding, F.; Jennings, M.P. An expedient total synthesis of (-)-dactylolide and formal synthesis of (-)-zampanolide. Org. Lett. 2005, 7, 2321-2324. (Pubitemid 40847627)
126. Hoye, T.R.; Hu, M.J. Macrolactonization via Ti(IV)-mediated epoxy-acid coupling: a total synthesis of (-)-dactylolide [and zampanolide]. J. Am. Chem. Soc. 2003, 125, 9576-9577. (Pubitemid 36975906)
127. Jennings, M.P. Total Synthesis of (-)-dactylolide and formal synthesis of (-)zampanolide. Lett. Org. Chem. 2006, 3, 78-81.